Humabs BioMed AG

Name: Humabs BioMed AG
Telephone: +41 91 825 63 80

Swiss Biotech Association

Member

Humabs BioMed, a subsidiary of Vir Biotechnology is a leading Swiss antibody therapeutics company that discovers and develops superior antibodies directly derived from individuals who have successfully overcome major diseases.

http://www.vir.bio
+41 91 825 63 80
info@humabs.ch
Filippo Riva

Location

Via dei Gaggini 3, 6500 Bellinzona, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2004
Number of employees in Switzerland

20-49

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

plusbiome AG

plusbiome AG is a Swiss startup company working at the interface of digital health and the microbiome. We design and market customised probiotics that truly support customers and their well-being,. Customers also profit from accompanying Apps.
4057 Basel

Member

SOMAGENETIX AG

Somagenetix is a Spin-off from the Univ of Zurich leveraging scientific, clinical and commercial expertise to solve unmet medical needs through gene therapy. We aim at becoming a leading gene therapy company with first-in-class and best-in-class treatment for phagocyte-related disorders.
8047 Zürich

Member

Adoram Therapeutics SA

Adoram Therapeutics is developing a suite of small molecule allosteric modulators for different indications. Our primary asset in the preclinical stage, is a negative allosteric modulator (NAM) of a clinically validated immuno-oncology target - the adenosine 2A receptor (A2AR).
1212 Grand-Lancy

Member